Animal Model Market size worth over $25 Bn by 2026

Animal Model Market size is set to surpass USD 25.2 billion by 2026, according to a new research report by Global Market Insights, Inc.

Physiological similarities in humans and animals will augment the demand for animal models

Physiological similarities between humans and animals is one of major factors that will boost the animal model market demand in the coming years. Animals and humans appear to be different, but they are similar at anatomical and physiological level. Therefore, 90% of the veterinary medicines are very similar to the medicines developed to treat humans. Human genome is 99% similar to genome in mice, including 85% of similarity in protein-coding regions between human and mice genome. This factor has led to the development of knockout and knock-in mice to study the effect of certain genes in humans.


Request Sample Buy NowInquiry Before Buying


Studies on mice have contributed significantly to understand the human biology as well as to test the efficacy of drugs and development of vaccines. The genome of humans is also 90% to 93% similar to genome in monkeys. Thus, clinical trials of several drugs have been performed in monkeys. Rats and guinea pigs are also increasingly being preferred as animal models owing to the similarities their genome with human genome.

Global Animal Model Market

Get more details on this report - Request Free Sample PDF

Growing demand for rat models will drive the animal model market growth

Rat model segment valued at more than USD 1.18 billion in 2019 led by to the physiological and anatomical similarities of rat genome to the human genome. According to the statistics by the Human Genome Project, approximately 2.75 billion bases of rat genome are similar to the bases of human genome. These biological similarities between rat and human will increase the demand and adoption of animals.

The advancements in genetic tools and increase in adoption of personalized medicines have led to an increased demand for rat model. Rat models are also increasingly preferred on account of the benefits such as their unlimited supply and ease of manipulation. Transgenic rat models are utilized for several neurological conditions and have proven to be useful for anxiety disorders. Also, the behavioral mechanisms involved in etiology and physiopathology of anxiety disorder can be monitored using the rat models.

Browse key industry insights spread across 596 pages with 902 market data tables & 20 figures & charts from the report, “Animal Model Market Size By Animal Type (Mice, Rats, Fish, Birds, Cattles, Pigs, Amphibians, Guinea Pigs, Dogs, Cats, Rabbits, Monkeys, Sheep, Hamsters), By Technology (CRISPR, Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer), By Applications, (Research & Development {Infectious Disease, Immunological Diseases, Cancer, Cardiovascular Diseases, Diabetes, Genetic Diseases, Neurological Diseases, Obesity, NAFLD/NASH, Renal disease, Diabetic eye disease, Fibrosis, Microbiome}, Production and Quality Control, Academics, Preclinical Applications {Infectious Disease, Immunological Diseases, Cancer, Cardiovascular Diseases, Diabetes, Genetic Diseases, Neurological Diseases, Obesity, NAFLD/NASH, Renal disease, Diabetic eye disease, Fibrosis, Microbiome}), By Use (Human and Veterinary), By End-use, (Companies {Pharmaceutical, Biotechnology, Cosmetics, Organizations {Government, Non-government}, Academic and Research Institutes, Contract Research Organizations (CRO)), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 – 2026”in detail along with the table of contents:

Increasing preference for microinjection technology will propel the market revenue

The microinjection technology segment in the animal model market is expected to witness around 7.3 % growth rate till 2026. Genetically engineered transgenic mouse and rat models are being generated at a moderate pace using microinjection technique for cardiovascular research. Microinjection techniques can also downregulate the gene expression in mice and rats. The renin-angiotensin system that provides information about the peptide system active in cardiovascular regulation can be studied on transgenic and knockout mouse models created using microinjection technique. These factors have augmented the adoption and demand for utilizing microinjection technique.

Rising interest in research and development will spur the animal model market value

The research and development segment valuation were more than USD         8.8 billion in 2019. Animals such as guinea pigs, mice and rats are extensively utilized for research and development activities. Growing need to develop treatment methods through research for infectious, metabolic diseases, cardiovascular diseases, cancer, diabetes, neurological disease, etc. is fostering the demand for animal models. Animals are also used majorly on a large scale in research and development applications to study disease characteristics and pathogenesis of diseases.

Growing prevalence of animal disorders will fuel the industry expansion

The veterinary segment in the animal model market is projected to expand at a CAGR of 7.3% through 2026. Increasing prevalence of various fatal animal disorders such as seizures and cancers has led to a rise in research activities pertaining to veterinary medicines. Dogs are considered as companion animals worldwide, that is influencing pet owners to adopt early treatments for dogs. These factors have led to an increase in demand for animal to develop potential treatments or medicines for the veterinary animals.

Increasing adoption of animal models by pharmaceutical companies

Animal model market for companies segment exceeded USD 9.14 billion in 2019 impelled by the increasing adoption of animal models for drug discovery along with development and production of novel products by pharmaceutical and biotechnology companies. Pharmaceutical companies are also engaged in preclinical examination as well as toxicity testing of drugs. Biotechnology and pharmaceutical companies focus towards utilizing animal models for developing novel drugs to seek profitable market value. Additionally, basic and applied medical and veterinary research projects are also supported by biotechnology companies.

Rising healthcare expenditure will create lucrative growth opportunity for the U.S. region

U.S. animal model market size was over USD 8.10 billion in 2019 owing to the increasing number government policies and clinical trials in the country pertaining to animal models. Growing healthcare expenditure has led to an increased investment in animal models by the biopharmaceutical companies. According to a report, in 2018, the research and development expenditure in the U.S by the biopharmaceutical companies was approximately USD 79.6 billion. Presence of well-established market players along with state-of-the-art healthcare facilities in the country will expand the market growth. Increasing biomedical research in the U.S. as well as rising preclinical activities by the contract research organizations (CROs) have augmented the demand for animal models.

Key players are adopting several business strategies to capture significant market share

Some of the major companies operational in the animal model market are Charles River, Envigo, genOway, Harbour BioMed, Janvier Labs, Horizon Discovery Group plc, The Jackson Laboratory and Taconic Biosciences Inc. among others. Increasing focus of the market leaders on manufacturing and developing innovative products for effective treatment of diseases will provide significant growth opportunities. These players are proposing strategic acquisitions, mergers, collaborations and partnerships in order to launch new animal models and strengthen their industrial position.

Explore More on Related Topics:


Chat with us
We use cookies to enhance user experience. (Privacy Policy) X